Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.17
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
15.22
0.33%
After-hours: Aug 15, 2025, 06:46 PM EDT
Immunovant Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | n/a | 160K | n/a | n/a | n/a | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 107K | 80K | 99K | 89K | 80K | 64K | 58K | 349K | 343K | 341K | 333K | 327K | 323K | 314K | 313K | 305K | 300K | 241K | n/a | n/a | n/a |
Gross Profit | -107K | 80K | -99K | -89K | -80K | 1.44M | -58K | -349K | -343K | -341K | -333K | -327K | -323K | -314K | -313K | -305K | -300K | -241K | n/a | n/a | n/a |
Operating Income | -127.22M | -113.83M | -114.3M | -115.74M | -94.28M | -80.88M | -51.53M | -58.21M | -73.95M | -64.31M | -44.03M | -49.61M | -40.38M | -47.27M | -41.38M | -37.65M | -29.89M | -28.92M | -31.64M | -20.97M | -26.59M |
Interest Income | 6.34M | 6.89M | 4.59M | 6.07M | 7.18M | 8.38M | 8.93M | 3.57M | 4.07M | 3.48M | 2.94M | 1.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -119.7M | -105.86M | -110.97M | -109.04M | -87.07M | -75.09M | -51.53M | -58.21M | -73.95M | -60.42M | -62.84M | -47.67M | -40.02M | -47.18M | -41.38M | -37.73M | -30.51M | -28.24M | -32.14M | -20.75M | -26.66M |
Net Income | -120.61M | -106.45M | -111.12M | -109.12M | -87.15M | -75.32M | -51.42M | -58.66M | -73.94M | -59.43M | -63.23M | -47.93M | -40.37M | -47.17M | -41.38M | -37.7M | -30.47M | -28.16M | -31.78M | -20.79M | -26.71M |
Selling & General & Admin | 26.02M | 20.25M | 19.78M | 18.47M | 18.73M | 14.76M | 13.21M | 13.84M | 15.4M | 12.42M | 11.78M | 11.88M | 11.95M | 15.24M | 11.52M | 16.29M | 11.18M | 10.3M | 10.55M | 9M | 9.66M |
Research & Development | 101.2M | 93.65M | 94.52M | 97.27M | 75.47M | 66.06M | 48.34M | 47.96M | 50.58M | 51.84M | 42.25M | 37.74M | 28.43M | 31.99M | 29.76M | 21.36M | 18.7M | 18.61M | 21.09M | 11.98M | 16.92M |
Other Expenses | n/a | n/a | n/a | n/a | 28K | n/a | n/a | 20K | 464K | 356K | n/a | n/a | 354K | 44K | -114K | -84K | n/a | n/a | n/a | n/a | -74K |
Operating Expenses | 127.22M | 113.91M | 114.3M | 115.74M | 94.2M | 80.81M | 61.55M | 61.8M | 65.98M | 64.26M | 54.03M | 49.61M | 40.38M | 47.23M | 41.27M | 37.65M | 29.89M | 28.92M | 31.64M | 20.97M | 26.59M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 80K | n/a | n/a | n/a | -64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 127.22M | 113.99M | 114.3M | 115.74M | 94.28M | 80.88M | 61.55M | 61.8M | 65.98M | 64.26M | 54.03M | 49.61M | 40.38M | 47.23M | 41.27M | 37.65M | 29.89M | 28.92M | 31.64M | 20.97M | 26.59M |
Income Tax Expense | 913K | 584K | 152K | 78K | 77K | 232K | -108K | 454K | -11K | -992K | 387K | 261K | 352K | -12K | -280K | -31K | -41K | -79K | -367K | 40K | 48K |
Shares Outstanding (Basic) | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M | 129.63M | 128.57M | 116.57M | 116.56M | 116.34M | 115.03M | 109.08M | 97.98M | 97.79M | 97.92M | 97.92M | 84.35M |
Shares Outstanding (Diluted) | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M | 129.63M | 128.57M | 116.57M | 116.56M | 116.34M | 115.03M | 109.08M | 97.98M | 97.97M | 97.92M | 97.92M | 84.35M |
EPS (Basic) | -0.71 | -0.64 | -0.76 | -0.74 | -0.6 | -0.52 | -0.36 | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 | -0.29 | -0.32 | -0.21 | -0.32 |
EPS (Diluted) | -0.71 | -0.64 | -0.76 | -0.74 | -0.6 | -0.52 | -0.36 | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 | -0.29 | -0.32 | -0.21 | -0.32 |
EBITDA | -119.59M | -88.51M | -114.2M | -115.65M | -94.2M | -80.81M | -61.49M | -61.74M | -65.92M | -64.2M | -53.98M | -49.57M | -40.33M | -47.19M | -41.24M | -37.43M | -29.86M | -28.28M | -31.62M | -20.96M | -26.58M |
EBIT | -119.7M | -88.62M | -114.3M | -115.74M | -94.28M | -80.88M | -61.55M | -61.8M | -65.98M | -64.26M | -54.03M | -49.61M | -40.38M | -47.23M | -41.27M | -37.65M | -29.89M | -28.24M | -31.64M | -20.97M | -26.59M |
Depreciation & Amortization | 107K | 109K | 99K | 89K | 80K | 64K | 58K | 56K | 343K | 341K | 333K | 327K | 323K | 314K | 313K | 305K | 300K | 241K | 19K | 14K | 10K |